|
US5023A
(en)
*
|
|
1847-03-20 |
|
Stocking-loom |
|
GB1562244A
(en)
*
|
1976-11-11 |
1980-03-05 |
Lock P M |
Wound dressing materials
|
|
GB1594389A
(en)
|
1977-06-03 |
1981-07-30 |
Max Planck Gesellschaft |
Dressing material for wounds
|
|
GB8516081D0
(en)
*
|
1985-06-25 |
1985-07-31 |
Ciba Geigy Ag |
Assay & purification of amyloid components
|
|
US6071517A
(en)
*
|
1986-07-07 |
2000-06-06 |
Medarex, Inc. |
Bispecific heteroantibodies with dual effector functions
|
|
DE3880647T2
(de)
*
|
1987-11-20 |
1993-11-18 |
Kanegafuchi Chemical Ind |
Sorbentmittel für Serum-Amyloid-Proteine.
|
|
US7070994B2
(en)
*
|
1988-03-21 |
2006-07-04 |
Oxford Biomedica (Uk) Ltd. |
Packaging cells
|
|
US5272258A
(en)
|
1989-06-29 |
1993-12-21 |
Rush-Presbyterian-St. Luke's Medical Center |
Monoclonal antibodies to C-reactive protein
|
|
US5092876A
(en)
*
|
1989-08-30 |
1992-03-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cell attachment peptides derived from amyloid P component
|
|
AU2158292A
(en)
|
1991-05-31 |
1993-01-08 |
New England Deaconess Hospital Corporation |
Cea-binding proteins and methods for their isolation and use
|
|
US5591709A
(en)
*
|
1991-08-30 |
1997-01-07 |
Life Medical Sciences, Inc. |
Compositions and methods for treating wounds
|
|
US5654186A
(en)
*
|
1993-02-26 |
1997-08-05 |
The Picower Institute For Medical Research |
Blood-borne mesenchymal cells
|
|
US6054121A
(en)
*
|
1993-02-26 |
2000-04-25 |
The Picower Institute For Medical Research |
Modulation of immune responses in blood-borne mesenchymal cells
|
|
US5804446A
(en)
*
|
1993-02-26 |
1998-09-08 |
The Picower Institute For Medical Research |
Blood-borne mesenchymal cells
|
|
WO1994027640A1
(en)
|
1993-05-27 |
1994-12-08 |
The Regents Of The University Of Michigan |
Method of treatment and prevention of immune complex-induced lung injury
|
|
US5698589A
(en)
*
|
1993-06-01 |
1997-12-16 |
International Medical Innovations, Inc. |
Water-based topical cream containing nitroglycerin and method of preparation and use thereof
|
|
GB9317120D0
(en)
*
|
1993-08-17 |
1993-09-29 |
Royal Postgrad Med School |
Human serum amyloid p component
|
|
US5981470A
(en)
|
1994-06-07 |
1999-11-09 |
The University Of Birmingham |
Uterine fibroid treatment
|
|
US5989811A
(en)
*
|
1994-09-29 |
1999-11-23 |
Urocor, Inc. |
Sextant core biopsy predictive mechanism for non-organ confined disease status
|
|
US5750345A
(en)
*
|
1995-10-31 |
1998-05-12 |
Evanston Hospital Corporation |
Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
|
|
DE69716741T2
(de)
|
1996-01-25 |
2003-06-12 |
Profylakse Aps, Odense |
Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten
|
|
US6365570B1
(en)
*
|
1997-10-10 |
2002-04-02 |
Universiteit Utrecht |
Pharmaceutical and diagnostic use of Serum Amyloid P component
|
|
KR20010041010A
(ko)
*
|
1998-02-17 |
2001-05-15 |
메다렉스, 인코포레이티드 |
Ｆｃ 수용체 리간드를 사용하여 마크로파지 매개 질환을치료하고 진단하는 방법
|
|
CN1235559C
(zh)
|
1998-03-11 |
2006-01-11 |
株式会社创研 |
皮肤水分保持能力的改善剂
|
|
JPH11319542A
(ja)
|
1998-05-08 |
1999-11-24 |
Tokuyama Corp |
超薄層の製造方法
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US6600019B2
(en)
*
|
2000-01-06 |
2003-07-29 |
Curagen Corporation |
Polypeptides and nucleic acids encoding same
|
|
EP1267795A1
(en)
|
2000-03-30 |
2003-01-02 |
Brennen Medical Inc. |
Anti-microbial and immunostimulating composition
|
|
US20040068095A1
(en)
*
|
2001-03-14 |
2004-04-08 |
Shimkets Richard A. |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
|
US6872541B2
(en)
*
|
2001-07-25 |
2005-03-29 |
Coulter International Corp. |
Method and compositions for analysis of pentraxin receptors as indicators of disease
|
|
US6537811B1
(en)
*
|
2001-08-01 |
2003-03-25 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of SAP-1 expression
|
|
US20030199442A1
(en)
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US7022476B2
(en)
*
|
2002-02-26 |
2006-04-04 |
New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
|
|
GB0211136D0
(en)
|
2002-05-15 |
2002-06-26 |
Univ London |
Treatment and prevention of tissue damage
|
|
BR0310084A
(pt)
*
|
2002-05-17 |
2005-02-15 |
Novartis Ag |
Composição farmacêutica compreendendo um inibidor de renina, um bloqueador de canal de cálcio e um diurético
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
US8946387B2
(en)
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
|
DK1534335T4
(en)
|
2002-08-14 |
2015-10-05 |
Macrogenics Inc |
FCGAMMARIIB-SPECIFIC ANTIBODIES AND PROCEDURES FOR USE THEREOF
|
|
US7763256B2
(en)
*
|
2002-12-23 |
2010-07-27 |
William Marsh Rice University |
Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
|
|
US8012472B2
(en)
|
2002-12-23 |
2011-09-06 |
William Marsh Rice University |
Compositions and methods for suppressing fibrocytes
|
|
PT1596880E
(pt)
|
2002-12-23 |
2011-06-06 |
Univ Rice William M |
Métodos e composições para suprimir a diferenciação de fibrócitos
|
|
CA2517037A1
(en)
|
2003-02-27 |
2004-09-10 |
Theravision Gmbh |
Method for reducing levels of c-reactive protein
|
|
JP5367982B2
(ja)
|
2004-04-16 |
2013-12-11 |
マクロジェニクス，インコーポレーテッド |
ＦｃγＲＩＩＢ特異的抗体とその利用法
|
|
CA2565874C
(en)
|
2004-05-10 |
2017-10-03 |
Macrogenics, Inc. |
Humanized fc.gamma.riib-specific antibodies and methods of use thereof
|
|
CA2568661A1
(en)
|
2004-06-03 |
2006-01-05 |
Medarex, Inc. |
Human monoclonal antibodies to fc gamma receptor i (cd64)
|
|
WO2006002930A2
(en)
|
2004-06-30 |
2006-01-12 |
Friedrich-Alexander- Universitaet Erlangen- Nuernberg |
FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS
|
|
AU2005282720B2
(en)
|
2004-09-02 |
2011-08-04 |
Genentech, Inc. |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
|
WO2006034373A2
(en)
*
|
2004-09-17 |
2006-03-30 |
Biomarin Pharmaceutical Inc. |
Variants and chemically-modified variants of phenylalanine ammonia-lyase
|
|
US7405302B2
(en)
|
2005-10-11 |
2008-07-29 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
EP1938104A2
(en)
|
2005-10-17 |
2008-07-02 |
Institute for Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
ES2599319T3
(es)
|
2006-06-26 |
2017-02-01 |
Macrogenics, Inc. |
Anticuerpos específicos de Fc RIIB y métodos de uso de éstos
|
|
ES2409756T3
(es)
*
|
2006-12-04 |
2013-06-27 |
Promedior, Inc. |
Combinación de SAP y de enalapril para su uso en tratamiento de trastornos fibróticos o fibroproliferativos
|
|
US8497243B2
(en)
*
|
2007-07-06 |
2013-07-30 |
Promedior, Inc. |
Methods and compositions useful in the treatment of mucositis
|
|
US9884899B2
(en)
*
|
2007-07-06 |
2018-02-06 |
Promedior, Inc. |
Methods for treating fibrosis using CRP antagonists
|
|
PL2185581T3
(pl)
*
|
2007-07-06 |
2016-01-29 |
Promedior Inc |
Sposoby i kompozycje użyteczne do leczenia zapalenia błony śluzowej
|
|
EP2405929B1
(en)
*
|
2009-03-11 |
2018-06-06 |
Promedior Inc. |
A sap polypeptide for use in the treatment of autoimmune disorders and graft vs host disease
|
|
CA2754961C
(en)
*
|
2009-03-11 |
2018-04-10 |
Promedior, Inc. |
Treatment and diagnostic methods for hypersensitive disorders
|
|
JP2012522798A
(ja)
|
2009-04-01 |
2012-09-27 |
プロメディオール， インコーポレイテッド |
血清アミロイドｐの肺および鼻への送達
|
|
UA110323C2
(en)
*
|
2009-06-04 |
2015-12-25 |
Promedior Inc |
Derivative of serum amyloid p and their receipt and application
|
|
EP2987803B1
(en)
*
|
2009-06-17 |
2018-08-29 |
Promedior Inc. |
Sap variants and their use
|